<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-33507</identifier>
<setSpec>1575-0922</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Asymptomatic primary hyperparathyroidism. How will the new consensus affect our praxis?</dc:title>
<dc:creator>Villabona, C</dc:creator>
<dc:language>es</dc:language>
<dc:publisher>Ediciones Doyma, S.L.</dc:publisher>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Endocrinol Nutr;51(6): 343-345, jun. 2004.</dc:source>
<dc:identifier>ibc-33507</dc:identifier>
<dc:title xml:lang="es">Hiperparatiroidismo primario asintomático. ¿Cómo afectará a nuestra praxis el nuevo consenso?</dc:title>
<dc:subject>^d29633</dc:subject>
<dc:subject>^d27977</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d22870</dc:subject>
<dc:subject>^d7140</dc:subject>
<dc:type>article</dc:type>
<dc:date>200406</dc:date>
</metadata>
</record>
</ibecs-document>
